CTOR Stock Price Prediction

Citius Oncology Inc

Add to Watchlist

Advanced Chart

1.670

-0.08(-4.571%)1D

Should I Buy Citius Oncology Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CTOR has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

CTOR stock price ended at $1.67 on Monday, after losing -4.57%

The Citius Oncology Inc stock price decreased by -4.57% on the last trading day (03 Nov 2025), dropping from 1.7 to 1.67. Throughout the last trading session, the stock experienced a fluctuation of 6.75% , ranging from a day low of $1.63 to a day high of 1.74. The price has declined in 3 of the last 10 days, resulting in a total change of -6.70% during this period. On the last day, trading volume increase by 9.67K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 95.74K shares were traded, amounting to approximately 160.14K.

CTOR Technical Signals

CTOR(Citius Oncology Inc Corp) has 2 buy signals and 5 sell signals now. The current trend is an uptrend starting from 2025-10-14. The total price change during this trend is -1.76%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of CTOR over the last 5 trading days is 342.88K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.

CTOR Moving Average Analysis

Citius Oncology Inc's overall moving average trend leans more bearish as of Tuesday, November 4, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.96, and $2.09. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.53, and $1.39. A break-down below any of these levels will issue sell signals.

CTOR Short Selling Analysis

The short sale ratio of Citius Oncology Inc(CTOR) as of 31 Oct 2025 is 15.67%, dropping from last trading day. With decreasing price from 1.73 to 1.75. The short sell activity indicate that short sellers may be experiencing short cover.

Technical Signal

Technical Signals Summary

Sell

Buy

Moving Average

Swing

Negative

Stock Price Below SMA_5

Short Term

Negative

SMA_5 Below SMA_20

Mid Term

Negative

SMA_20 Below SMA_60

Long Term

Positive

SMA_60 Above SMA_200

Short Selling

Close Price

Short Sale Ratio

Short Sale Volume

2 Bullish Signals

When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Commodity Channel Index (20 days, 0.015 constant)

CCI_20_0.015 < -100

-103.551

Bullish

Williams %R (14 days)

WILLR_14 < -80

-86.567

Bullish

5 Bearish Signals

When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 < 0

-0.0772

Bearish

Momentum (10 days)

MOM_10 < 0

-0.12

Bearish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 < 0

-0.0371

Bearish

Moving Average

Price crosses below 5-day SMA

Bearish

Moving Average

Price crosses below 10-day SMA

Bearish

CTOR Stock Forecast

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Month	Min. Price	Avg. Price	Max. Price	Potential ROI
Month	Min. Price	Avg. Price	Max. Price	Potential ROI
No data

Unlock Free Stock Price Forecast

In 2026, Citius Oncology Inc (CTOR) is anticipated to change hands in a trading channel between $0.00 and $0.00.

Citius Oncology Inc Stock Forecast 2026

CTOR Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Citius Oncology Inc(CTOR), our algorithm predicts CTOR's 1-month price at $1.76, with an 0.72%upwardshift. Using a similarity score up to 94.89%and other factors, This forecast updates weekly, adjusting for significant deviations.

Similar Chart

The price prediction chart for Citius Oncology Inc (CTOR.O) stock, as of Sunday, November 2, 2025 , forecasts a 0.72% change over the next month, based on its high correlation with IMXI.O stock patterns. The similarity between their price movements over the analyzed periods is 94.89%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

CTOR

Future prediction

Up: 0.72%

Full Access. No Commitment.

7 Days Free!

AI Stock Picker

AI Swing Trade Signal

AI Earning Prediction

AI Screener

AI Financial Agent Help You Do Research

GET STARTED!

Already have an account? Sign In Here

IMXI

Up: 0.72%Similarity: 94.89%

Name

Similarity

Up/Down

IMXI.O

94.89%

+0.72%

AVDL.O

94.86%

+12.26%

VLGEA.O

94.61%

+2.22%

TRT.A

94.47%

-11.51%

OUST.N

94.19%

+54.26%

RXRX.O

94.06%

-17.82%

NTR.N

93.76%

-2.94%

RXT.O

93.58%

-7.60%

PACB.O

93.54%

-12.03%

TPB.N

93.36%

+13.29%

CTOR Seasonality Analysis

Based on CTOR's historical stock price data across all years, the probability of a positive return in November is33.33%, suggesting it maynotbe an ideal month to invest in CTOR. In contrast,Januaryoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.

However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Citius Oncology Inc (CTOR.O) stock in January has the highest probability of a positive return (100.00%), while July has the lowest probability (33.33%).

Performance Seasonality

The chart shows Citius Oncology Inc. (CTOR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.